Jin Yang Pharmaceutical Co., Ltd. announced that it has received KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors
November 26, 2021
Share
On November 26, 2021, Jin Yang Pharmaceutical Co., Ltd. closed the transaction.
JIN YANG PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacturing and distributing of medicine and medicine supplies. The Companyâs products consist of drugs for the circulation systems, digestive organs and the central nervous systems, antibiotics, metabolic drugs, and others including antihistaminic agents, anti-inflammatory analgesic drugs, antimicrobials, muscle relaxants, psychotropic agents, high blood pressure medicines, diabetes medicines, injection medicines, skin disease medicines, nutritional supplements, anemia medicines, dental care drugs, ophthalmology care drugs and others. The Company distributes its products within domestic market and to overseas markets.
Jin Yang Pharmaceutical Co., Ltd. announced that it has received KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors